CPIX vs T · rev $10.4M vs P/E 7.4, rev $125.65B
Cumberland Pharmaceuticals Inc (CPIX) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
Latest reported T revenue for 2025-12-31 was $125.65B. Net income was $21.95B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
CPIX currently screens at market cap $86.9M. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the CPIX and T stock pages for the full models.
Not investment advice.